|
C3ORF21 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.017200E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.626470E-02 |
| Normal-vs-Stage2 |
1.886440E-01 |
| Normal-vs-Stage3 |
2.582600E-03 |
| Normal-vs-Stage4 |
1.719910E-03 |
| Stage1-vs-Stage2 |
6.333800E-01 |
| Stage1-vs-Stage3 |
1.587810E-01 |
| Stage1-vs-Stage4 |
1.438380E-01 |
| Stage2-vs-Stage3 |
1.951180E-01 |
| Stage2-vs-Stage4 |
1.125590E-01 |
| Stage3-vs-Stage4 |
7.619200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.116300E-03 |
| Normal-vs-AfricanAmerican |
1.121430E-01 |
| Normal-vs-Asian |
1.171510E-02 |
| Caucasian-vs-AfricanAmerican |
9.992400E-01 |
| Caucasian-vs-Asian |
4.350200E-01 |
| AfricanAmerican-vs-Asian |
6.201400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.095900E-02 |
| Normal-vs-Female |
1.476140E-03 |
| Male-vs-Female |
2.146800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.115520E-02 |
| Normal-vs-Age(41-60Yrs) |
3.298400E-03 |
| Normal-vs-Age(61-80Yrs) |
1.585870E-02 |
| Normal-vs-Age(81-100Yrs) |
1.830950E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.554200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.858000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.417000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.286600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.432600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.739000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.793900E-02 |
| Classical-VS-Follicular |
8.673200E-01 |
| Classical-VS-Other |
4.055400E-01 |
| Classical-VS-Normal |
4.140000E-02 |
| Tall-VS-Follicular |
1.737000E-01 |
| Tall-VS-Other |
9.750000E-01 |
| Tall-VS-Normal |
1.090120E-02 |
| Follicular-VS-Other |
4.515000E-01 |
| Follicular-VS-Normal |
5.256200E-02 |
| Other-VS-Normal |
6.627700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.385900E-02 |
| Normal-vs-N1 |
2.457600E-03 |
| N0-vs-N1 |
1.310990E-01 |
|
|
